Literature DB >> 32516628

Benzodiazepine misuse among adults receiving psychiatric treatment.

R Kathryn McHugh1, Andrew D Peckham2, Thröstur Björgvinsson2, Francesca M Korte3, Courtney Beard2.   

Abstract

Benzodiazepines are among the most commonly prescribed psychiatric medications and have the potential for misuse. People with psychiatric disorders may have a heightened liability to the reinforcing effects of benzodiazepines. Yet, the prevalence of benzodiazepine misuse in psychiatric care settings is not well characterized. The aim of the current study was to characterize the prevalence and correlates of benzodiazepine misuse in a sample of adults receiving psychiatric treatment (N = 589). The majority of participants reported a lifetime history of benzodiazepine prescription (68%) and 26% reported a lifetime history of misuse (defined as use without a prescription or at a dose or frequency higher than prescribed). Multivariable analyses indicated that history of a benzodiazepine prescription and drug use problems were significantly associated with lifetime benzodiazepine misuse. People with a history of benzodiazepine prescription had four times higher odds of misusing benzodiazepines and the primary source of misused benzodiazepines was from family or friends. Results suggest that benzodiazepine misuse is not exclusive to substance use disorder populations. The misuse of benzodiazepines should be assessed in psychiatric settings. Further research is needed to understand the impact of benzodiazepine misuse in this population and to develop tools to identify those at risk for misuse.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety; Benzodiazepines; Prescription drug misuse; Substance misuse

Mesh:

Substances:

Year:  2020        PMID: 32516628      PMCID: PMC7483788          DOI: 10.1016/j.jpsychires.2020.05.020

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  24 in total

Review 1.  What constitutes prescription drug misuse? Problems and pitfalls of current conceptualizations.

Authors:  Sean P Barrett; Jessica R Meisner; Sherry H Stewart
Journal:  Curr Drug Abuse Rev       Date:  2008-11

2.  Nonmedical prescription sedative/tranquilizer use in alcohol and opioid use disorders.

Authors:  Victoria R Votaw; Katie Witkiewitz; Linda Valeri; Olivera Bogunovic; R Kathryn McHugh
Journal:  Addict Behav       Date:  2018-08-14       Impact factor: 3.913

3.  Nonmedical benzodiazepine use in adults with alcohol use disorder: The role of anxiety sensitivity and polysubstance use.

Authors:  R Kathryn McHugh; Rachel Geyer; Sterling Karakula; Margaret L Griffin; Roger D Weiss
Journal:  Am J Addict       Date:  2018-07-20

4.  The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test.

Authors:  K Bush; D R Kivlahan; M B McDonell; S D Fihn; K A Bradley
Journal:  Arch Intern Med       Date:  1998-09-14

5.  Improving the efficiency of drug use disorder screening in psychiatric settings: validation of a single-item screen.

Authors:  Bridget A Hearon; Casey L Pierce; Thröstur Björgvinsson; Garrett M Fitzmaurice; Shelly F Greenfield; Roger D Weiss; Alisa B Busch
Journal:  Am J Drug Alcohol Abuse       Date:  2015-03       Impact factor: 3.829

6.  The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study.

Authors:  C de las Cuevas; E J Sanz; J A de la Fuente; J Padilla; J C Berenguer
Journal:  Addiction       Date:  2000-02       Impact factor: 6.526

7.  Benzodiazepine use in the United States.

Authors:  Mark Olfson; Marissa King; Michael Schoenbaum
Journal:  JAMA Psychiatry       Date:  2015-02       Impact factor: 21.596

Review 8.  Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2008-01-12       Impact factor: 3.533

9.  Validation of the PHQ-9 in a psychiatric sample.

Authors:  C Beard; K J Hsu; L S Rifkin; A B Busch; T Björgvinsson
Journal:  J Affect Disord       Date:  2015-12-31       Impact factor: 4.839

10.  Patterns in Outpatient Benzodiazepine Prescribing in the United States.

Authors:  Sumit D Agarwal; Bruce E Landon
Journal:  JAMA Netw Open       Date:  2019-01-04
View more
  3 in total

1.  Association of New Perioperative Benzodiazepine Use With Persistent Benzodiazepine Use.

Authors:  Jason D Wright; Jacob C Cogan; Yongmei Huang; Ana I Tergas; Caryn M St Clair; June Y Hou; Fady Khoury-Collado; Allison Gockley; Melissa Accordino; Alexander Melamed; Dawn L Hershman
Journal:  JAMA Netw Open       Date:  2021-06-01

2.  Development and implementation of SafeMedWaste, a chemical denaturant for non-hazardous disposal of controlled medications.

Authors:  Emma Leishman; Yizhong Wang; Reddy Channu; Evan Boyst; Marshall Hartmann; Justin Stas
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

3.  Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway.

Authors:  Christer Frode Aas; Jørn Henrik Vold; Rolf Gjestad; Svetlana Skurtveit; Aaron Guanliang Lim; Kristian Varden Gjerde; Else-Marie Løberg; Kjell Arne Johansson; Lars Thore Fadnes
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-02-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.